<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2024//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_240101.dtd">
<PubmedArticleSet>
<PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Automated"><PMID Version="1">36822818</PMID><DateCompleted><Year>2023</Year><Month>02</Month><Day>27</Day></DateCompleted><DateRevised><Year>2023</Year><Month>04</Month><Day>23</Day></DateRevised><Article PubModel="Print"><Journal><ISSN IssnType="Print">2053-3624</ISSN><JournalIssue CitedMedium="Print"><Volume>10</Volume><Issue>1</Issue><PubDate><Year>2023</Year><Month>Feb</Month></PubDate></JournalIssue><Title>Open heart</Title><ISOAbbreviation>Open Heart</ISOAbbreviation></Journal><ArticleTitle>Cardiac abnormalities in Long COVID 1-year post-SARS-CoV-2 infection.</ArticleTitle><ELocationID EIdType="pii" ValidYN="Y">e002241</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.1136/openhrt-2022-002241</ELocationID><Abstract><AbstractText Label="BACKGROUND">Long COVID is associated with multiple symptoms and impairment in multiple organs. Cross-sectional studies have reported cardiac impairment to varying degrees by varying methodologies. Using cardiac MR (CMR), we investigated a 12-month trajectory of abnormalities in Long COVID.</AbstractText><AbstractText Label="OBJECTIVES">To investigate cardiac abnormalities 1-year post-SARS-CoV-2 infection.</AbstractText><AbstractText Label="METHODS">534 individuals with Long COVID underwent CMR (T1/T2 mapping, cardiac mass, volumes, function and strain) and multiorgan MRI at 6 months (IQR 4.3-7.3) since first post-COVID-19 symptoms. 330 were rescanned at 12.6 (IQR 11.4-14.2) months if abnormal baseline findings were reported. Symptoms, questionnaires and blood samples were collected at both time points. CMR abnormalities were defined as &#x2265;1 of low left or right ventricular ejection fraction (LVEF), high left or right ventricular end diastolic volume, low 3D left ventricular global longitudinal strain (GLS), or elevated native T1 in &#x2265;3 cardiac segments. Significant change over time was reported by comparison with 92 healthy controls.</AbstractText><AbstractText Label="RESULTS">Technical success of multiorgan and CMR assessment in non-acute settings was 99.1% and 99.6% at baseline, and 98.3% and 98.8% at follow-up. Of individuals with Long COVID, 102/534 (19%) had CMR abnormalities at baseline; 71/102 had complete paired data at 12 months. Of those, 58% presented with ongoing CMR abnormalities at 12 months. High sensitivity cardiac troponin I and B-type natriuretic peptide were not predictive of CMR findings, symptoms or clinical outcomes. At baseline, low LVEF was associated with persistent CMR abnormality, abnormal GLS associated with low quality of life and abnormal T1 in at least three segments was associated with better clinical outcomes at 12 months.</AbstractText><AbstractText Label="CONCLUSION">CMR abnormalities (left entricular or right ventricular dysfunction/dilatation and/or abnormal T1mapping), occurred in one in five individuals with Long COVID at 6 months, persisting in over half of those at 12 months. Cardiac-related blood biomarkers could not identify CMR abnormalities in Long COVID.</AbstractText><AbstractText Label="TRIAL REGISTRATION NUMBER">NCT04369807.</AbstractText><CopyrightInformation>&#xa9; Author(s) (or their employer(s)) 2023. Re-use permitted under CC BY. Published by BMJ.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Roca-Fernandez</LastName><ForeName>Adriana</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Perspectum Ltd, Oxford, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Wamil</LastName><ForeName>Malgorzata</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Department of Cardiology, Great Western Hospital Foundation NHS Trust, Swindon, UK.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Cardiology, Oxford Radcliffe Hospitals NHS Trust, Oxford, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Telford</LastName><ForeName>Alison</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Perspectum Ltd, Oxford, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Carapella</LastName><ForeName>Valentina</ForeName><Initials>V</Initials><AffiliationInfo><Affiliation>Perspectum Ltd, Oxford, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Borlotti</LastName><ForeName>Alessandra</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Perspectum Ltd, Oxford, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Monteiro</LastName><ForeName>David</ForeName><Initials>D</Initials><AffiliationInfo><Affiliation>Perspectum Ltd, Oxford, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Thomaides-Brears</LastName><ForeName>Helena</ForeName><Initials>H</Initials><AffiliationInfo><Affiliation>Perspectum Ltd, Oxford, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Kelly</LastName><ForeName>Matt</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Perspectum Ltd, Oxford, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Dennis</LastName><ForeName>Andrea</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Perspectum Ltd, Oxford, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Banerjee</LastName><ForeName>Rajarshi</ForeName><Initials>R</Initials><AffiliationInfo><Affiliation>Perspectum Ltd, Oxford, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Robson</LastName><ForeName>Matthew</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Perspectum Ltd, Oxford, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Brady</LastName><ForeName>Michael</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Perspectum Ltd, Oxford, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Lip</LastName><ForeName>Gregory Y H</ForeName><Initials>GYH</Initials><AffiliationInfo><Affiliation>Liverpool Centre for Cardiovascular Science, University of Liverpool, Liverpool, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Bull</LastName><ForeName>Sacha</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Department of Cardiology, Royal Berkshire Hospital NHS Foundation Trust, Reading, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Heightman</LastName><ForeName>Melissa</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Department of Respiratory Medicine, University College London Hospitals NHS Trust, London, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Ntusi</LastName><ForeName>Ntobeko</ForeName><Initials>N</Initials><AffiliationInfo><Affiliation>Medicine, University of Cape Town, Cape Town, South Africa.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Banerjee</LastName><ForeName>Amitava</ForeName><Initials>A</Initials><Identifier Source="ORCID">0000-0001-8741-3411</Identifier><AffiliationInfo><Affiliation>Institute of Health Informatics, University College London, London, UK ami.banerjee@ucl.ac.uk.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Cardiology, University College London Hospitals NHS Trust, London, UK.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Cardiology, Barts Health NHS Trust, London, UK.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><DataBankList CompleteYN="Y"><DataBank><DataBankName>ClinicalTrials.gov</DataBankName><AccessionNumberList><AccessionNumber>NCT04369807</AccessionNumber></AccessionNumberList></DataBank></DataBankList><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType></PublicationTypeList></Article><MedlineJournalInfo><Country>England</Country><MedlineTA>Open Heart</MedlineTA><NlmUniqueID>101631219</NlmUniqueID><ISSNLinking>2053-3624</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D013318" MajorTopicYN="N">Stroke Volume</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000086382" MajorTopicYN="Y">COVID-19</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000094024" MajorTopicYN="N">Post-Acute COVID-19 Syndrome</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D003430" MajorTopicYN="N">Cross-Sectional Studies</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D011788" MajorTopicYN="N">Quality of Life</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D011237" MajorTopicYN="N">Predictive Value of Tests</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000086402" MajorTopicYN="N">SARS-CoV-2</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D016278" MajorTopicYN="N">Ventricular Function, Right</DescriptorName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">COVID-19</Keyword><Keyword MajorTopicYN="N">EPIDEMIOLOGY</Keyword><Keyword MajorTopicYN="N">Magnetic Resonance Imaging</Keyword><Keyword MajorTopicYN="N">Myocarditis</Keyword></KeywordList><CoiStatement>Competing interests: AD, AT, VC, ABo, SF, MP, ARF, HTB, MK, MR, MB and RB are employees of Perspectum.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2022</Year><Month>12</Month><Day>20</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2023</Year><Month>2</Month><Day>9</Day></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2023</Year><Month>2</Month><Day>23</Day><Hour>21</Hour><Minute>13</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2023</Year><Month>2</Month><Day>24</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2023</Year><Month>3</Month><Day>3</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2023</Year><Month>2</Month><Day>23</Day></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">36822818</ArticleId><ArticleId IdType="pmc">PMC9950586</ArticleId><ArticleId IdType="doi">10.1136/openhrt-2022-002241</ArticleId><ArticleId IdType="pii">openhrt-2022-002241</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Shi S, Qin M, Shen B, et al. . Association of cardiac injury with mortality in hospitalized patients with COVID-19 in Wuhan, China. JAMA Cardiol 2020;5:802&#x2013;10. 10.1001/jamacardio.2020.0950</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/jamacardio.2020.0950</ArticleId><ArticleId IdType="pmc">PMC7097841</ArticleId><ArticleId IdType="pubmed">32211816</ArticleId></ArticleIdList></Reference><Reference><Citation>Han H, Xie L, Liu R, et al. . Analysis of heart injury laboratory parameters in 273 COVID-19 patients in one hospital in Wuhan, China. J Med Virol 2020;92:819&#x2013;23. 10.1002/jmv.25809</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/jmv.25809</ArticleId><ArticleId IdType="pmc">PMC7228305</ArticleId><ArticleId IdType="pubmed">32232979</ArticleId></ArticleIdList></Reference><Reference><Citation>Akhmerov A, Marb&#xe1;n E. COVID-19 and the heart. Circ Res 2020;126:1443&#x2013;55. 10.1161/CIRCRESAHA.120.317055</Citation><ArticleIdList><ArticleId IdType="doi">10.1161/CIRCRESAHA.120.317055</ArticleId><ArticleId IdType="pmc">PMC7188058</ArticleId><ArticleId IdType="pubmed">32252591</ArticleId></ArticleIdList></Reference><Reference><Citation>Heightman M, Prashar J, Hillman TE, et al. . Post-COVID-19 assessment in a specialist clinical service: a 12-month, single-centre, prospective study in 1325 individuals. BMJ Open Respir Res 2021;8:e001041. 10.1136/bmjresp-2021-001041</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/bmjresp-2021-001041</ArticleId><ArticleId IdType="pmc">PMC8587466</ArticleId><ArticleId IdType="pubmed">34764200</ArticleId></ArticleIdList></Reference><Reference><Citation>Cassar MP, Tunnicliffe EM, Petousi N, et al. . Symptom persistence despite improvement in cardiopulmonary health - insights from longitudinal CMR, CPET and lung function testing post-covid-19. EClinicalMedicine 2021;41:101159. 10.1016/j.eclinm.2021.101159</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.eclinm.2021.101159</ArticleId><ArticleId IdType="pmc">PMC8527025</ArticleId><ArticleId IdType="pubmed">34693230</ArticleId></ArticleIdList></Reference><Reference><Citation>Kim JY, Han K, Suh YJ. Prevalence of abnormal cardiovascular magnetic resonance findings in recovered patients from COVID-19: a systematic review and meta-analysis. J Cardiovasc Magn Reson 2021;23:100. 10.1186/s12968-021-00792-7</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s12968-021-00792-7</ArticleId><ArticleId IdType="pmc">PMC8414035</ArticleId><ArticleId IdType="pubmed">34479603</ArticleId></ArticleIdList></Reference><Reference><Citation>Halushka MK, Vander Heide RS. Myocarditis is rare in COVID-19 autopsies: cardiovascular findings across 277 postmortem examinations. Cardiovasc Pathol 2021;50:107300. 10.1016/j.carpath.2020.107300</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.carpath.2020.107300</ArticleId><ArticleId IdType="pmc">PMC7583586</ArticleId><ArticleId IdType="pubmed">33132119</ArticleId></ArticleIdList></Reference><Reference><Citation>Tanacli R, Doeblin P, G&#xf6;tze C, et al. . COVID-19 vs. classical myocarditis associated myocardial injury evaluated by cardiac magnetic resonance and endomyocardial biopsy. Front Cardiovasc Med 2021;8:737257. 10.3389/fcvm.2021.737257</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fcvm.2021.737257</ArticleId><ArticleId IdType="pmc">PMC8739473</ArticleId><ArticleId IdType="pubmed">35004872</ArticleId></ArticleIdList></Reference><Reference><Citation>Borlotti A, Thomaides-Brears H, Georgiopoulos G, et al. . The additive value of cardiovascular magnetic resonance in convalescent COVID-19 patients. Front Cardiovasc Med 2022;9:854750. 10.3389/fcvm.2022.854750</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fcvm.2022.854750</ArticleId><ArticleId IdType="pmc">PMC9021393</ArticleId><ArticleId IdType="pubmed">35463767</ArticleId></ArticleIdList></Reference><Reference><Citation>Petersen SE, Friedrich MG, Leiner T, et al. . Cardiovascular magnetic resonance for patients with COVID-19. JACC Cardiovasc Imaging 2022;15:685&#x2013;99. 10.1016/j.jcmg.2021.08.021</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jcmg.2021.08.021</ArticleId><ArticleId IdType="pmc">PMC8514168</ArticleId><ArticleId IdType="pubmed">34656482</ArticleId></ArticleIdList></Reference><Reference><Citation>Dennis A, Wamil M, Alberts J, et al. . Multiorgan impairment in low-risk individuals with post-COVID-19 syndrome: a prospective, community-based study. BMJ Open 2021;11:e048391. 10.1136/bmjopen-2020-048391</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/bmjopen-2020-048391</ArticleId><ArticleId IdType="pmc">PMC8727683</ArticleId><ArticleId IdType="pubmed">33785495</ArticleId></ArticleIdList></Reference><Reference><Citation>Messroghli DR, Radjenovic A, Kozerke S, et al. . Modified look-locker inversion recovery (MOLLI) for high-resolution T1 mapping of the heart. Magn Reson Med 2004;52:141&#x2013;6. 10.1002/mrm.20110</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/mrm.20110</ArticleId><ArticleId IdType="pubmed">15236377</ArticleId></ArticleIdList></Reference><Reference><Citation>Corica B, Marra AM, Basili S, et al. . Prevalence of right ventricular dysfunction and impact on all-cause death in hospitalized patients with COVID-19: a systematic review and meta-analysis. Sci Rep 2021;11:17774. 10.1038/s41598-021-96955-8</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41598-021-96955-8</ArticleId><ArticleId IdType="pmc">PMC8423751</ArticleId><ArticleId IdType="pubmed">34493763</ArticleId></ArticleIdList></Reference><Reference><Citation>Bartlett JW, Frost C. Reliability, repeatability and reproducibility: analysis of measurement errors in continuous variables. Ultrasound Obstet Gynecol 2008;31:466&#x2013;75. 10.1002/uog.5256</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/uog.5256</ArticleId><ArticleId IdType="pubmed">18306169</ArticleId></ArticleIdList></Reference><Reference><Citation>Medzikovic L, Cunningham CM, Li M, et al. . Sex differences underlying preexisting cardiovascular disease and cardiovascular injury in COVID-19. J Mol Cell Cardiol 2020;148:25&#x2013;33. 10.1016/j.yjmcc.2020.08.007</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.yjmcc.2020.08.007</ArticleId><ArticleId IdType="pmc">PMC7442559</ArticleId><ArticleId IdType="pubmed">32835666</ArticleId></ArticleIdList></Reference><Reference><Citation>Bienvenu LA, Noonan J, Wang X, et al. . Higher mortality of COVID-19 in males: sex differences in immune response and cardiovascular comorbidities. Cardiovasc Res 2020;116:2197&#x2013;206. 10.1093/cvr/cvaa284</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/cvr/cvaa284</ArticleId><ArticleId IdType="pmc">PMC7665363</ArticleId><ArticleId IdType="pubmed">33063089</ArticleId></ArticleIdList></Reference><Reference><Citation>Huang L, Yao Q, Gu X, et al. . 1-year outcomes in hospital survivors with COVID-19: a longitudinal cohort study. Lancet 2021;398:747&#x2013;58. 10.1016/S0140-6736(21)01755-4</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0140-6736(21)01755-4</ArticleId><ArticleId IdType="pmc">PMC8389999</ArticleId><ArticleId IdType="pubmed">34454673</ArticleId></ArticleIdList></Reference><Reference><Citation>Capuano A, Rossi F, Paolisso G. Covid-19 kills more men than women: an overview of possible reasons. frontiers in cardiovascular medicine. 2020: 7. Available: https://www.frontiersin.org/article/10.3389/fcvm.2020.00131</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7380096</ArticleId><ArticleId IdType="pubmed">32766284</ArticleId></ArticleIdList></Reference><Reference><Citation>Raman B, Cassar MP, Tunnicliffe EM, et al. . Medium-term effects of SARS-CoV-2 infection on multiple vital organs, exercise capacity, cognition, quality of life and mental health, post-hospital discharge. EClinicalMedicine 2021;31:100683. 10.1016/j.eclinm.2020.100683</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.eclinm.2020.100683</ArticleId><ArticleId IdType="pmc">PMC7808914</ArticleId><ArticleId IdType="pubmed">33490928</ArticleId></ArticleIdList></Reference><Reference><Citation>Puntmann VO, Carerj ML, Wieters I, et al. . Outcomes of cardiovascular magnetic resonance imaging in patients recently recovered from coronavirus disease 2019 (COVID-19). JAMA Cardiol 2020;5:1265&#x2013;73. 10.1001/jamacardio.2020.3557</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/jamacardio.2020.3557</ArticleId><ArticleId IdType="pmc">PMC7385689</ArticleId><ArticleId IdType="pubmed">32730619</ArticleId></ArticleIdList></Reference><Reference><Citation>Brito D, Meester S, Yanamala N, et al. . High prevalence of pericardial involvement in college student athletes recovering from COVID-19. JACC Cardiovasc Imaging 2021;14:541&#x2013;55. 10.1016/j.jcmg.2020.10.023</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jcmg.2020.10.023</ArticleId><ArticleId IdType="pmc">PMC7641597</ArticleId><ArticleId IdType="pubmed">33223496</ArticleId></ArticleIdList></Reference><Reference><Citation>Kotecha T, Knight DS, Razvi Y, et al. . Patterns of myocardial injury in recovered troponin-positive COVID-19 patients assessed by cardiovascular magnetic resonance. Eur Heart J 2021;42:1866&#x2013;78. 10.1093/eurheartj/ehab075</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/eurheartj/ehab075</ArticleId><ArticleId IdType="pmc">PMC7928984</ArticleId><ArticleId IdType="pubmed">33596594</ArticleId></ArticleIdList></Reference><Reference><Citation>Joy G, Artico J, Kurdi H, et al. . Prospective case-control study of cardiovascular abnormalities 6 months following mild COVID-19 in healthcare workers. JACC Cardiovasc Imaging 2021;14:2155&#x2013;66. 10.1016/j.jcmg.2021.04.011</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jcmg.2021.04.011</ArticleId><ArticleId IdType="pmc">PMC8105493</ArticleId><ArticleId IdType="pubmed">33975819</ArticleId></ArticleIdList></Reference><Reference><Citation>Li X, Wang H, Zhao R, et al. . Elevated extracellular volume fraction and reduced global longitudinal strains in participants recovered from COVID-19 without clinical cardiac findings. Radiology 2021;299:E230&#x2013;40. 10.1148/radiol.2021203998</Citation><ArticleIdList><ArticleId IdType="doi">10.1148/radiol.2021203998</ArticleId><ArticleId IdType="pmc">PMC7808090</ArticleId><ArticleId IdType="pubmed">33434112</ArticleId></ArticleIdList></Reference><Reference><Citation>Xie Y, Xu E, Bowe B, et al. . Long-term cardiovascular outcomes of COVID-19. Nat Med 2022;28:583&#x2013;90. 10.1038/s41591-022-01689-3</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41591-022-01689-3</ArticleId><ArticleId IdType="pmc">PMC8938267</ArticleId><ArticleId IdType="pubmed">35132265</ArticleId></ArticleIdList></Reference><Reference><Citation>Ferreira VM, Schulz-Menger J, Holmvang G, et al. . Cardiovascular magnetic resonance in nonischemic myocardial inflammation: expert recommendations. J Am Coll Cardiol 2018;72:3158&#x2013;76. 10.1016/j.jacc.2018.09.072</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jacc.2018.09.072</ArticleId><ArticleId IdType="pubmed">30545455</ArticleId></ArticleIdList></Reference><Reference><Citation>O&#x2019;Gallagher K, Shek A, Bean DM, et al. . Pre-existing cardiovascular disease rather than cardiovascular risk factors drives mortality in COVID-19. BMC Cardiovasc Disord 2021;21:327. 10.1186/s12872-021-02137-9</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s12872-021-02137-9</ArticleId><ArticleId IdType="pmc">PMC8254437</ArticleId><ArticleId IdType="pubmed">34217220</ArticleId></ArticleIdList></Reference><Reference><Citation>Knight DS, Kotecha T, Razvi Y, et al. . COVID-19: myocardial injury in survivors. Circulation 2020;142:1120&#x2013;2. 10.1161/CIRCULATIONAHA.120.049252</Citation><ArticleIdList><ArticleId IdType="doi">10.1161/CIRCULATIONAHA.120.049252</ArticleId><ArticleId IdType="pmc">PMC7492396</ArticleId><ArticleId IdType="pubmed">32673505</ArticleId></ArticleIdList></Reference><Reference><Citation>Wall EC FD, Prescott G, Dehbi HM, et al. . STIMULATE-ICP: a pragmatic, multi-centre, cluster randomised trial of an integrated care pathway with a nested, phase III, open label, adaptive platform randomised drug trial in individuals with long COVID: a structured protocol [In press]. PLOS One 2023.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9931100</ArticleId><ArticleId IdType="pubmed">36791116</ArticleId></ArticleIdList></Reference><Reference><Citation>Petersen EL, Go&#xdf;ling A, Adam G, et al. . Multi-organ assessment in mainly non-hospitalized individuals after SARS-CoV-2 infection: the Hamburg City health study COVID programme. Eur Heart J 2022;43:1124&#x2013;37. 10.1093/eurheartj/ehab914</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/eurheartj/ehab914</ArticleId><ArticleId IdType="pmc">PMC8755397</ArticleId><ArticleId IdType="pubmed">34999762</ArticleId></ArticleIdList></Reference><Reference><Citation>Ferreira VM, Piechnik SK, Dall&#x2019;Armellina E, et al. . Native T1-mapping detects the location, extent and patterns of acute myocarditis without the need for gadolinium contrast agents. J Cardiovasc Magn Reson 2014;16:36. 10.1186/1532-429X-16-36</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/1532-429X-16-36</ArticleId><ArticleId IdType="pmc">PMC4041901</ArticleId><ArticleId IdType="pubmed">24886708</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle></PubmedArticleSet>